Skip to main content

Table 1

From: Different metabolic and anthropometric characteristics of TVD, CBV or KVX associated with nevirapine: Results from the "NEVIRAPINE COMPANION" cohort

Median* or %° Total TVD n = 142 pts CBV n = 62 pts KVX n = 40 pts p-value
Age, (yrs)* 44.0 44.5 42.0 44.0 .173
CDC Group C° 25.8 25.4 18 9 .793
Nadir CD4 (c/μL)* 156 141 166 188 .457
NRTI cum exp (mths)* 119 132 112 126 .073
Current NRTI Tx (mths)* 18.1 12.3 24.9 21.7 <.001
PI cum exp (mths)* 42 47 36 38 .100
NNRTI cum exp (mths)* 45 40 52 55 .038
Current NEV Tx (mths)* 20 13.4 24.9 21.8 .003
BMI 22.5 22.5 23.55 21.54 .020
Waist (cm)* 83 83 87 80 .009
Total fat mass (gr)* 9905 9538 11926 8656 .012
Total lean mass (gr)* 50754 51590 50754 45940 .257
% fat in legs* 9.14 9.10 12.01 7.43 .080
% fat in legs/BMI* 0.40 0.41 0.48 0.35 .239
HOMA 2.79 2.78 2.78 2.82 .993
TG (mg/dL)* 130 120 133 142 .200
TC (mg/dL)* 199 194 196 215 .040
HDL (mg/dL)* 49 49 51 48 .120
LDL (mg/dL)* 123 122 113 137 .028
ApoB (mg/dL)* 102 99 94.5 115.5 .009
ApoA1 (mg/dL)* 151 146 163.5 157 <.001